Found 0 matching trials
Camrelizumab in Combination With Chemotherapy or Apatinib Mesylate as First-Line Treatment for R/M HNSCC
PHASE2This study is the first clinical study of first-line treatment of head and ...
Location
the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
PHASE2RATIONALE: Antithymocyte globulin, clofarabine, and rituximab may stop the ...
Location
Masonic Cancer Center at University of Minnesota
Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route (V205C-011)
PHASE3Primary objective:
To compare if, when given concomitantly with VARIVAX® b...
Location
Multiple Locations
Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
PHASE3This study is a Phase 3, randomized, modified double-blind study which aims...
Status
Active Not Recruiting
Location
Alabama Clinical Therapeutics - Birmingham - St. Vincent's Drive- Site Number : 8400013
Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old Children
PHASE3The purpose of this study is to demonstrate, in 12-23 month old children, t...
Location
GSK Investigational Site
Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers
PHASE3The aim of the study was to assess whether the second CYD dengue vaccinatio...
Location
Multiple Locations
Treatments Being Tested
Live, attenuated, recombinant dengue serotype 1, 2, 3, and 4 virusDTaP IPV//Hib vaccinePlaceboMeasles, mumps, and rubella vaccinePneumococcal vaccineLive, attenuated, recombinant dengue serotype 1, 2, 3, and 4 virusDTaP IPV//Hib vaccinePlaceboMeasles, mumps, and rubella vaccinePneumococcal vaccine Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children
PHASE3The purpose of the study is to compare the immunogenicity and safety of a b...
Location
GSK Investigational Site
ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)
PHASE3This study will compare Measles, Mumps, Rubella, and Varicella Vaccine (V22...
Location
Multiple Locations
Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines
N/AThis study will collect data on the safety of the MMRV vaccine (Priorix-Tet...
Location
Multiple Locations
Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136
PHASE3This Phase 3b study is being conducted for the purpose of registration of t...
Location
GSK Investigational Site